{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T14:51:06Z","timestamp":1782139866415,"version":"3.54.5"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,9,14]]},"DOI":"10.7759\/cureus.45254","type":"journal-article","created":{"date-parts":[[2023,9,14]],"date-time":"2023-09-14T20:38:56Z","timestamp":1694723936000},"source":"Crossref","is-referenced-by-count":1,"title":["Transient Neurologic Deficits Following Intramuscular Epinephrine Administration for the Treatment of Anaphylaxis"],"prefix":"10.7759","author":[{"given":"Curtis S","family":"Pacheco","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Riesing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cody","family":"Ashcroft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2005.12.1303","article-title":"Second symposium on the definition and management of anaphylaxis: summary report--Second National Institute of Allergy and Infectious Disease\/Food Allergy and Anaphylaxis Network symposium","volume":"117","author":"Sampson HA","year":"2006","unstructured":"Sampson HA, Mu\u00f1oz-Furlong A, Campbell RL, et al.. Second symposium on the definition and management of anaphylaxis: summary report--Second National Institute of Allergy and Infectious Disease\/Food Allergy and Anaphylaxis Network symposium. J Allergy Clin Immunol. 2006, 117:391-397. 10.1016\/j.jaci.2005.12.1303","journal-title":"J Allergy Clin Immunol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2005.01.010","article-title":"The diagnosis and management of anaphylaxis: an updated practice parameter","volume":"115","author":"Joint Task Force on Practice Parameters; American Academy of Allergy","year":"2005","unstructured":"Joint Task Force on Practice Parameters; American Academy of Allergy, Asthma and Immunology; American College of Allergy, Asthma and Immunology; Joint Council of Allergy, Asthma and Immunology. The diagnosis and management of anaphylaxis: an updated practice parameter. J Allergy Clin Immunol. 2005, 115:483-523. 10.1016\/j.jaci.2005.01.010","journal-title":"J Allergy Clin Immunol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3238\/arztebl.2018.0528","article-title":"Adrenaline in the acute treatment of anaphylaxis","volume":"115","author":"Ring J","year":"2018","unstructured":"Ring J, Klimek L, Worm M. Adrenaline in the acute treatment of anaphylaxis. Dtsch Arztebl Int. 2018, 115:528-534. 10.3238\/arztebl.2018.0528","journal-title":"Dtsch Arztebl Int"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1111\/j.1398-9995.2008.01733.x","article-title":"Epinephrine: the drug of choice for anaphylaxis. A statement of the World Allergy Organization","volume":"63","author":"Kemp SF","year":"2008","unstructured":"Kemp SF, Lockey RF, Simons FE. Epinephrine: the drug of choice for anaphylaxis. A statement of the World Allergy Organization. Allergy. 2008, 63:1061-1070. 10.1111\/j.1398-9995.2008.01733.x","journal-title":"Allergy"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.15171\/jept.2018.13","article-title":"Cardiovascular complications and acute ischemic stroke after the treatment with epinephrine in an anaphylactic patient","volume":"5","author":"K\u00f6se A","year":"2019","unstructured":"K\u00f6se A, Yarka\u00e7 A, Bozali G, Babu\u015f SB, Alt\u0131nsoy E. Cardiovascular complications and acute ischemic stroke after the treatment with epinephrine in an anaphylactic patient. J Emerg Pract Trauma. 2019, 5:32-34. 10.15171\/jept.2018.13","journal-title":"J Emerg Pract Trauma"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.clineuro.2011.03.014","article-title":"Intracerebral hemorrhage following epinephrine application for anaphylactic reaction","volume":"113","author":"Wendt M","year":"2011","unstructured":"Wendt M, Audebert H, Nolte CH. Intracerebral hemorrhage following epinephrine application for anaphylactic reaction. Clin Neurol Neurosurg. 2011, 113:699-700. 10.1016\/j.clineuro.2011.03.014","journal-title":"Clin Neurol Neurosurg"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jemermed.2008.01.008","article-title":"Intracranial hemorrhage after prehospital administration of intramuscular epinephrine","volume":"40","author":"Levis JT","year":"2011","unstructured":"Levis JT, Ford JB, Kuo AM. Intracranial hemorrhage after prehospital administration of intramuscular epinephrine. J Emerg Med. 2011, 40:107-110. 10.1016\/j.jemermed.2008.01.008","journal-title":"J Emerg Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1007\/BF03018600","article-title":"Cerebral infarction following carotid arterial injection of adrenaline","volume":"52","author":"Saxena N","year":"2005","unstructured":"Saxena N, Sharma M. Cerebral infarction following carotid arterial injection of adrenaline. Can J Anaesth. 2005, 52:119. 10.1007\/BF03018600","journal-title":"Can J Anaesth"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/S1081-1206(10)60714-4","article-title":"Fatal anaphylaxis: postmortem findings and associated comorbid diseases","volume":"98","author":"Greenberger PA","year":"2007","unstructured":"Greenberger PA, Rotskoff BD, Lifschultz B. Fatal anaphylaxis: postmortem findings and associated comorbid diseases. Ann Allergy Asthma Immunol. 2007, 98:252-257. 10.1016\/S1081-1206(10)60714-4","journal-title":"Ann Allergy Asthma Immunol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1111\/j.1398-9995.2008.01926.x","article-title":"Adrenaline for the treatment of anaphylaxis: cochrane systematic review","volume":"64","author":"Sheikh A","year":"2009","unstructured":"Sheikh A, Shehata YA, Brown SG, Simons FE. Adrenaline for the treatment of anaphylaxis: cochrane systematic review. Allergy. 2009, 64:204-212. 10.1111\/j.1398-9995.2008.01926.x","journal-title":"Allergy"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2222.2000.00864.x","article-title":"Lessons for management of anaphylaxis from a study of fatal reactions","volume":"30","author":"Pumphrey RS","year":"2000","unstructured":"Pumphrey RS. Lessons for management of anaphylaxis from a study of fatal reactions. Clin Exp Allergy. 2000, 30:1144-1150. 10.1046\/j.1365-2222.2000.00864.x","journal-title":"Clin Exp Allergy"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1111\/cea.12520","article-title":"Anaphylaxis and cardiovascular disease: therapeutic dilemmas","volume":"45","author":"Lieberman P","year":"2015","unstructured":"Lieberman P, Simons FE. Anaphylaxis and cardiovascular disease: therapeutic dilemmas. Clin Exp Allergy. 2015, 45:1288-1295. 10.1111\/cea.12520","journal-title":"Clin Exp Allergy"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/180451-transient-neurologic-deficits-following-intramuscular-epinephrine-administration-for-the-treatment-of-anaphylaxis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:05:54Z","timestamp":1707509154000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/180451-transient-neurologic-deficits-following-intramuscular-epinephrine-administration-for-the-treatment-of-anaphylaxis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,14]]},"references-count":12,"URL":"https:\/\/doi.org\/10.7759\/cureus.45254","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9,14]]}}}